Financials

  • Market Capitalization 351.79 M
  • Employee 533
  • Founded 2002
  • CEO N/A
  • Website www.vandapharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000HT5MG6
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.7
Rapporto prezzo/fatturato
1.88

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3148
XFOR
X4 Pharmaceuticals, Inc. - Common Stock
3.84 USD-4.48%-1.79%-6.34%+29.29%362.19 M USD
3179
LXEO
Lexeo Therapeutics, Inc. - Common Stock
4.69 USD+1.52%-7.31%-0.64%+12.74%368.27 M USD
3210
PRLD
Prelude Therapeutics Incorporated - Common Stock
4.50 USD+2.51%-10.89%+2.97%+455.56%358.40 M USD
3217
FATE
Fate Therapeutics, Inc. - Common Stock
2.92 USD-2.34%+0.34%+43.84%+156.14%340.35 M USD

Notizie